Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 24.55B | 24.97B | 22.57B | 20.45B | 18.25B | 17.68B |
Gross Profit | 5.77B | 5.68B | 5.27B | 4.81B | 4.38B | 3.90B |
EBITDA | 3.76B | 3.50B | 3.28B | 3.31B | 2.54B | 2.09B |
Net Income | 2.41B | 2.37B | 2.11B | 2.21B | 1.63B | 1.36B |
Balance Sheet | ||||||
Total Assets | 27.43B | 28.23B | 26.23B | 24.02B | 21.90B | 20.68B |
Cash, Cash Equivalents and Short-Term Investments | 15.88B | 16.20B | 14.19B | 13.05B | 11.85B | 11.13B |
Total Debt | 360.00M | 0.00 | 17.02M | 23.28M | 16.82M | 21.30M |
Total Liabilities | 6.47B | 6.70B | 6.52B | 6.11B | 5.80B | 5.50B |
Stockholders Equity | 20.96B | 21.53B | 19.71B | 17.91B | 16.10B | 15.17B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 2.57B | 1.79B | 2.05B | 1.58B | 2.01B |
Operating Cash Flow | 0.00 | 2.77B | 1.85B | 2.09B | 1.65B | 2.12B |
Investing Cash Flow | 0.00 | -506.84M | -121.89M | -1.21B | -318.93M | 354.53M |
Financing Cash Flow | 0.00 | -302.26M | -582.60M | -267.83M | -617.69M | -258.77M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥37.36B | 16.49 | 2.60% | 11.00% | 33.93% | ||
77 Outperform | ¥27.14B | 11.28 | 1.14% | 11.94% | 14.10% | ||
74 Outperform | ¥1.36T | 30.11 | 1.63% | 24.10% | 11.27% | ||
72 Outperform | $637.47B | 33.20 | 13.64% | 0.43% | 6.92% | 25.38% | |
70 Outperform | ¥1.09T | 19.32 | 16.17% | 4.17% | 15.49% | 18.42% | |
68 Neutral | ¥234.20B | 14.88 | 7.50% | 2.60% | 9.27% | 5.76% | |
40 Underperform | ¥29.66B | 81.36 | ― | 5.38% | -140.87% |